"Underwater" Technique With Submucosal Solution of Viscose Solution -SIC 8000 (EleviewTM) - For Endoscopic Resection of Cole-rectal Polyps With Signs of Fibrosis.
UEMREleview
1 other identifier
interventional
40
1 country
1
Brief Summary
All procedures are performed in the investigator's outpatient gastroenterology and digestive endoscopy unit by experienced endoscopists in conventional mucosectomies of the lower intestinal tract. Before the procedure each patient, a normal endoscopic procedure. At the site of the lesion the lumen will be completely decompressed with aspiration of the gas, and then again relaxed with the instillation of only water. The EleviewTM will be injected into the submucosa in such quantities as to obtain a satisfactory lift of the lesion. The lesion will then be removed with a diathermic loop, preferably en-bloc, and in any case up to macroscopic evidence of complete resection. All the removed material will be stored and sent to histological analysis. Tolerability score will be recorded during the procedure. Any "bleeding" (both intra- and post-procedural), perforation, post-polypectomy syndrome, stenosis or death in the 6 months following the procedure will be born "complication". A surveillance colonoscopy including biopsy sampling of the research site scheduled 6 months after the procedure
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 26, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 26, 2018
CompletedFirst Posted
Study publicly available on registry
November 28, 2018
CompletedJanuary 13, 2020
September 1, 2019
6 months
November 26, 2018
January 10, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Macroscopically complete resection rate
6 Months
6-month recurrence rate;
6 Months
Rate of adverse events (according to the lexiconA ASGE).
6 Months
Study Arms (1)
"Underwater" mucosectomy
OTHER"Underwater" mucosectomy with submucosal injection of viscous solution -SIC 8000 (EleviewTM)
Interventions
"Underwater" mucosectomy with submucosal injection of viscous solution -SIC 8000 (EleviewTM)
Eligibility Criteria
You may qualify if:
- Age\> 18 years.
- Signing of informed consent.
- Possibility of being subjected to the diagnostic and therapeutic procedures of the study.
- Presence of colo-rectal polypoid lesions ≥ 15mm presenting macroscopic aspects of fibrosis as a consequence of previous incomplete treatments or biopsies or relapses after previous removal.
You may not qualify if:
- Highly indicative morphological characteristics of carcinoma with submucosal invasion (Ulceration, Pit Pattern Vn according to Kudo et al.18)
- Pregnancy or breastfeeding
- ASA\> 3
- Unstable personality or unable to adhere to the protocol procedures.
- Inability to provide informed consent.
- Injury not reachable endoscopically.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Endoscopy Unit, Gastroenterology Department, Humanitas Research Hospital
Rozzano, Milano, 20089, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2018
First Posted
November 28, 2018
Study Start
June 1, 2018
Primary Completion
November 26, 2018
Study Completion
November 26, 2018
Last Updated
January 13, 2020
Record last verified: 2019-09